The PR is good news. At least they are moving forward with it and hopefully we'll see patient enrollment in Q1 2015 if not earlier if all goes smoothly.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.